Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder

Journal of Affective Disorders

Volumn 128, Issue 3, 2011, Pages 305-308

  Schaffer, Charles B ^a   Schaffer, Linda C ^b   Miller, Amber R ^c   Hang, Evelyn ^d   Nordahl, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sutter Community Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Hypnotic; Insomnia

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; ESZOPICLONE; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; RAMELTEON; TRANQUILIZER; VALPROIC ACID; ZALEPLON; ZOLPIDEM TARTRATE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; BITTER TASTE; CHRONIC INSOMNIA; COGNITIVE DEFECT; DAYTIME SEDATION; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FRACTURE; HUMAN; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NAUSEA; NIGHTMARE; OUTPATIENT; PARASOMNIA; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SEDATION; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACETAMIDES; ADOLESCENT; ADULT; AZABICYCLO COMPOUNDS; BIPOLAR DISORDER; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INDENES; MALE; PIPERAZINES; PYRIDINES; PYRIMIDINES; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 78751638668     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.07.018     Document Type: Article

References (13)

1. E. Altena, H. Vrenken, Y.D. Van Der Werf, O.A. van den Heuvel, and E.J.W. Van Someren Reduced orbitofrontal and parietal gray matter in chronic insomnia: a voxel-based morphometric study Biol. Psychiatry 67 2010 182 185
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fourth Edition 2000 American Psychiatric Association Washington, DC Text Revision
3. C. Colombo, F. Benedetti, B. Barbini, E. Campori, and E. Smeraldi Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression Psychiatry Res. 86 1999 267 270
4. A.G. Harvey Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation Am. J. Psychiatry 165 2008 820 829
5. A.G. Harvey, D.A. Schmidt, A. Scarna, and C.N. Semler Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems Am. J. Psychiatry 162 2005 50 57
6. K. Kato, K. Hirai, K. Nishiyama, O. Uchikawa, K. Fukatsu, S. Ohkawa, Y. Kawamata, S. Hinuma, and M. Miyamoto Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist Neuropharmacology 48 2005 301 310
7. National Institutes of Health state of the science conference statement Manifestations and management of chronic insomnia in adults Sleep 28 2005 1049 1057
8. D.T. Plante, and J.W. Winkelman Sleep disturbance in bipolar disorder: therapeutic implications Am. J. Psychiatry 165 2008 830 843
9. A.F. Schatzberg, C.B. Nemeroff, Textbook of Psychopharmacology Fourth Edition 2009 1259 1260
10. M. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res. 73 3 1997 159 171
11. T.A. Wehr, F.K. Goodwin, A. Wirz-Justice, J. Breitmaier, and C. Craig 48-hour sleep-wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments Arch. Gen. Psychiatry 39 1982 559 565
12. T.A. Wehr, D.A. Sack, and N.E. Rosenthal Sleep reduction as a final common pathway in the genesis of mania Am. J. Psychiatry 144 1987 201 204
13. M. Wojnar, M.A. Ilgen, J. Wojnar, R.J. McCammon, M. Valenstein, and K.J. Brower Sleep problems and suicidality in the national comorbidity survey replication J. Psychiatr. Res. 43 2009 526 531